SpineEx withdrew its initial public offering at the end of last week, according to a Renaissance Capital report.
Here are four key points:
1. The company filed the $17 million IPO in September.
2. Without disclosing the reason, SpineEx withdrew its plans for the IPO.
3. Founded in 2017, the Fremont, Calif.-based spine device company received FDA clearance for its lateral lumbar interbody fusion device earlier this year.
4. Prior to its withdrawal, ThinkEquity was the sole bookrunner on the deal, according to the report.